Zhejiang, China

Xiaolei Wang

This inventor holds 1 USPTO granted patent. Top assignee: Technoderma Medicines Pte Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaolei Wang. Retrieved from https://idiyas.com/inventor/xiaolei-wang-leaiiflz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaolei Wang: Innovator in Small Molecule Compounds

Introduction

Xiaolei Wang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule compounds. His work focuses on creating innovative solutions for medical applications.

Latest Patents

Xiaolei Wang holds a patent for a small molecule compound that serves as a highly efficient and specific JAK kinase inhibitor. This compound is characterized by its ability to act as a Tyk2 inhibitor and/or a JAK1 inhibitor, and/or a JAK1/Tyk2 dual inhibitor. The patent highlights the compound's various forms, including stereoisomers, geometric isomers, and pharmaceutically acceptable salts.

Career Highlights

Wang is associated with Technoderma Medicines Pte Ltd., where he continues to advance his research and development efforts. His innovative approach to drug design has positioned him as a key player in the pharmaceutical industry.

Collaborations

Xiaolei Wang collaborates with talented individuals such as Xiang Jiang and Yuting Cai, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Xiaolei Wang's work in small molecule compounds exemplifies the innovative spirit of modern science. His contributions to JAK kinase inhibitors are paving the way for new therapeutic options in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…